The pharmacodynamic characterization of an antisense oligonucleotide against monoamine oxidase-B (MAO-B) in rat brain striatal tissue

Cellular and Molecular Neurobiology

Volumn 21, Issue 1, 2001, Pages 53-64

  Sprague, Jon E ^a   Worst, Travis J ^a,d   Mosler, Charles R ^a   Nichols, David E ^b   Kane, Michael D ^c  

^a OHIO NORTHERN UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Genomic Solutions Inc   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Antisense oligonucleotide; MAO B; Striatum

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; PHENETHYLAMINE; SELEGILINE;

AGING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; HISTOCHEMISTRY; MALE; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

ANIMALS; CORPUS STRIATUM; DOPAMINE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROXYINDOLEACETIC ACID; INJECTIONS, INTRAVENTRICULAR; MALE; MONOAMINE OXIDASE; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEROTONIN;

EID: 0034984177     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007121312399     Document Type: Article

References (28)

1. Mescaline analogs, p-Dialkylamino-β-phenethylamine and 9-(β-aminoethyl)julolidine
2. Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites
3. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain
4. Pharmacology of selegiline
5. Dopamine is a monoamine oxidase B substrate in man
6. Increased stress response and β-phenylethylamine in MAOB-deficient mice
7. Some observations upon a new inhibitor of monoamine oxidase in brain tissue
8. Demonstration of monoamine oxidase type B in serotonergic and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique
9. Monoamine oxidases: Distribution in the cat brain studied by enzyme- and immunohistochemistry: Recent progress
10. R-(-)-deprenyl (Selegiline, Moverganr®) facilitates the activity of the nigrostriatal dopaminergic neuron
11. The striatal dopamine dependency of life span in male rats: Longevity study with (-)deprenyl
12. Some puzzling pharmacological effects of monoamine oxidase inhibitors
13. A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides
14. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons
15. Trimethyltin increases interleukin (IL)-1α, IL-6 and tumor necrosis factor α mRNA levels in rat hippocampus
16. Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives
17. Time course of nigrostriatal degeneration in Parkinson's disease
18. Biphasic and region-specific MAO-B response to aging in normal human brain
19. Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives
20. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage
21. Dopamine turnover and glutathione oxidation: Implications for Parkinson disease
22. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine
23. In vitro trapping of free radicals by the monoamine oxidase B inhibitors deprenyl and MDL 72,974A
24. Gene inhibition using antisense oligodeoxynucleotides
25. Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA
26. Distinct monoamine oxidase A and B populations in primate brain
27. Intracellular distribution of monoamine oxidase A in selected regions of rat and monkey brain and spinal cord